Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/24 09:26 | 10/24/24 | LH | Health | Health | Medical Laboratories | Anderson Kerrii B | NC | D | 2 | S.m | -455 | 227.50 | 0 | -2 | 15 | D | ||||||||||||||||
8/21/24 09:08 | 8/19/24 | LH | Health | Health | Medical Laboratories | Van Der Vaart Sandra D | NC | O | EVP,GC | 1 | S | -454 | 227.05 | 0 | -2 | 4 | D | |||||||||||||||
8/19/24 10:22 | 8/15/24 | LH | Health | Health | Medical Laboratories | Eisenberg Glenn A | NC | O | CFO,EVP | 1 | S | -3,360 | 223.99 | 0 | -15 | 31 | D | |||||||||||||||
8/7/24 08:47 | 8/5/24 | LH | Health | Health | Medical Laboratories | Berberian Lance | NC | O | EVP,CIO, | 1 | S | -2,771 | 229.10 | 0 | -12 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |